AstraZeneca Voydeya approved in EU as add-on treatment to ravulizumab or eculizumab for adults with PNH who have residual haemolytic anaemia Ruchika Sharma26 April 2024 4:10 PM ISTAstraZeneca has announced that Voydeya (danicopan) has been approved in the European Union (EU) as an add-on to ravulizumab or...
USFDA nod to Voydeya as add on therapy to ravulizumab or eculizumab for extravascular haemolysis in adults with rare disease PNH: AstraZeneca Ruchika Sharma1 April 2024 3:18 PM ISTCambridge: AstraZeneca has announced that Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the...
AstraZeneca blood disorder drug recommended for EU nod Ruchika Sharma27 Feb 2024 11:29 AM ISTCambridge: AstraZeneca has announced that Voydeya (danicopan) has been recommended for marketing authorisation in the European Union (EU) as an...
AstraZeneca Voydeya approved in Japan for paroxysmal nocturnal haemoglobinuria Ruchika Sharma21 Jan 2024 12:30 PM ISTCambridge: AstraZeneca has announced that Voydeya (danicopan) has been approved in Japan for the treatment of paroxysmal nocturnal...
